Inhibikase Therapeutics (IKT) Misses Q3 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: IKT) | Delayed: 1.68 +0.06 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.62 | 52 Week High | $ | |||
| Open | $1.64 | 52 Week Low | $ | |||
| Day High | $1.70 | P/E | N/A | |||
| Day Low | $1.64 | EPS | $ | |||
| Volume | 74,447 | |||||
